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Historically, Western equine encephalomyelitis and St.
Louis encephalitis caused substantial human and equine
illness and death in California. This study describes the epi-
demiology of encephalitis with data from 13,807 patients
hospitalized in California with acute encephalitis from 1990
through 1999. The incidence of encephalitis hospitaliza-
tions decreased over this period. The greatest proportion of
case-patients was hospitalized in the winter. Encephalitis of
unspecified origin was the most common diagnosis, and
arboviral encephalitis was the least common. Some
California counties had concurrent increases in encephali-
tis rates and in detected arboviral activity in sentinel chick-
ens and mosquito vectors. However, a diagnosis of
arboviral encephalitis was made for few hospitalized
patients in these counties during these periods. Although
some arboviral encephalitis cases may have been undiag-
nosed, such cases probably did not occur frequently. Active
hospital-based surveillance during periods of heightened
sylvatic arboviral activity could increase detection of arbovi-
ral encephalitis.
E
ncephalitis, or inflammation of the brain, is a serious
clinical syndrome with many potential infectious,
postinfectious, and postimmunization causes (1,2).
Recognized causes of infectious encephalitis in humans
include, but are not limited to, herpes simplex viruses,
arboviruses, lymphocytic choriomeningitis, mumps,
cytomegalovirus, Epstein-Barr virus, human herpesvirus 6,
and enteroviruses. The epidemiology of encephalitis in the
United States is characterized by the predominance of
cases with unknown origin (3–6). 
Historically, Western equine encephalomyelitis (WEE)
and St. Louis encephalitis (SLE) viruses (WEEV and
SLEV, respectively) were important causes of encephalitis
in California residents, particularly in the Central Valley
and southern California (7). Since the 1960s, the incidence
of WEE and SLE has decreased dramatically, although
sporadic cases are still reported (7). Most recently, two
small SLE epidemics were reported in Los Angeles and the
Central Valley in 1984 and 1989, respectively (8,9).
Reports of arboviral encephalitis cases are uncommon in
southern California, despite evidence of endemic WEEV
and SLEV activity in birds and mosquito vectors in that
area (10). Sylvatic West Nile virus (WNV) activity was
recently detected for the first time in California, which
may contribute to changes in the epidemiology of central
nervous system disease (11). The 1999 appearance of
WNV in New York and adjacent states produced illness
and death among humans, horses, and several avian
species (12). 
Healthcare providers and diagnostic laboratories in
California are required to report human encephalitis cases
to the California Department of Health Services (CDHS)
under Title 17 of the California Code of Regulations. The
code stipulates that the reporter identify the cause as viral,
bacterial, fungal, or parasitic. Because this surveillance
system is passive, human encephalitis cases may be under-
reported, even when the cause of encephalitis is identified
(5). In this study, hospital discharge data were used to esti-
mate the incidence of acute encephalitis and to provide a
basis for comparison with the number of reported cases of
encephalitis. In addition, the encephalitis hospitalization
rates of districts with differing levels of sylvatic arboviral
activity were compared. These data may provide a useful
baseline to evaluate trends in encephalitis hospitalizations
in California, including unusual occurrences of arboviral
encephalitis. Such baseline data may prove useful given
the recent detection of WNV in California and the poten-
tial for introduction of other arboviral agents.
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Data Sources
Hospital discharge data (public use version A) include
information on approximately 3.5 million yearly dis-
charges from all California hospitals that serve the civilian
population; federal facilities or state hospitals for patients
with mental disorders or developmental disabilities are
excluded (13). The data do not contain patient names or
other personal identifiers. Patients discharged from acute-
care hospitals in California from 1990 through 1999 were
the source population for the present study. Patients with
acute infectious or unspecified encephalitis as the principal
diagnosis or one of the 24 additional diagnoses were
selected by using the International Classification of
Diseases, 9th Revision, Clinical Modification (ICD-9-CM
codes listed in Table 1 [14]). Only data on the first hospi-
talization of patients with more than one encephalitis-relat-
ed hospitalization were included in the analysis. When
available, the record linkage number, based on an encrypt-
ed Social Security number, was used to identify patients
with multiple hospitalizations. Patients with no record
linkage number were assumed to have been hospitalized
only once.
The annual number of reported encephalitis cases from
1990 through 1999 was obtained from CDHS, Division of
Communicable Disease Control. Arboviral surveillance
data were obtained from published reports (15–17). 
Data Analysis
The average age- and sex-specific incidence rates of
encephalitis (cases per 105 person-years) were calculated
by using the California population projections for 1995
(18). These estimates were adjusted to account for the pro-
portion of cases with missing demographic information by
assuming that the proportion with missing data is the same
within each subgroup. A 95% confidence interval was cal-
culated for each group-specific rate. Such rates were
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Table 1. Diagnoses for acute infectious or unspecified encephalitis among hospitalized patients in California, 1990–1999
a  
Diagnosis (ICD -9-CM
b)  No. of encephalitis diagnoses (%)
c
 
Encephalitis of unspecified cause    
Unspecified cause of encephalitis (323.9)  4,841 (34.7) 
Unspecified non -arthropod-borne viral diseases of CNS  (049.9)  2,932 (21.0) 
Viral encephalitis with specified cause, not arboviral    
Acute paralytic poliomyelitis specified as bulbar (045.0)   44 (0.3) 
Other specified nonarthropodborne vira l diseases of central nervous system (049.8)   288 (2.1) 
Herpetic meningoencephalitis (054.3)   2,007 (14.4) 
Encephalomyelitis due to rubella (056.01)   6 (0.04) 
Rabies (071)  13 (0.1) 
Mumps encephalitis (072.2)   14 (0.1) 
Encephalitis in viral diseases classi fied elsewhere (323.0)   76 (0.5) 
Other causes of encephalitis    
Other encephalitis due to infection classified elsewhere (323.4)  117 (0.8) 
Other causes of encephalitis (323.8)   2,196 (15.8) 
Postinfectious causes of encephalitis    
Postvaricella encephaliti s (052.0)  421 (3.0) 
Post measles encephalitis (055.0)   41 (0.3) 
Postinfectious encephalitis (323.6)   595 (4.3) 
Bacterial/rickettsial causes of encephalitis    
Tuberculous encephalitis or myelitis (013.6)   30 (0.2) 
Meningococcal encephalitis (036.1)   128 (0.9) 
Syphilitic encephalitis (094.81)   11 (0.1) 
Encephalitis in rickettsial diseases classified elsewhere (323.1)  0 (0) 
Parasitic/protozoal causes of encephalitis    
Meningoencephalitis attributable to toxoplasmosis (130.0)   82 (0.6) 
Meningoencephalitis at tributable to Naegleria (136.2)  10 (0.1) 
Encephalitis in protozoal diseases classified elsewhere (323.2)  4 (0.03) 
Arthropodborne viral encephalitis    
Mosquitoborne viral encephalitis (062.0–062.9)  63 (0.5) 
Tickborne viral encephalitis (063.0–063.9)  6 (0.04) 
Viral encephalitis trans mitted by other and unspecified arthropods (064)   14 (0.1) 
Total no. of encephalitis diagnoses
d  13,939 
aPatients with a concurrent diagnosis of AIDS are excluded.  
bInternational Classification of Diseases, 9th Revision, Clinical Modification.  
cSource: Office of Statewide Health Planning and Development, Patient Discharge Data, Public Version A.   
dTotal number of encephalitis diagnoses is greater than the number of encephalitis patients (n = 13,807) because some patients had two or more 
encephalitis diagnoses.  compared by using a chi-square test for proportions.
Annual incidence rates were calculated by using annual
population estimates for California (19). Linear trends in
proportions were evaluated by using a chi-square test for
trend (20). Significance probabilities <0.05 (p values)
were considered a strong indication of systematic influ-
ence (i.e., not chance variation). 
Encephalitis hospitalization rates were evaluated sepa-
rately for Sacramento and Yolo, Sutter and Yuba, and
Riverside and Imperial Counties. These counties had a suf-
ficient population size to allow calculation of meaningful
rates and had reported sylvatic arboviral activity during the
study period. The number of encephalitis cases was insuffi-
cient to calculate county-specific rates for each category of
encephalitis and therefore the rates are for all encephalitis
hospitalizations. Data were combined for Sacramento-Yolo
and Sutter-Yuba to reflect the collection of arboviral sur-
veillance data by a single bi-county agency for each of
these districts, and for Riverside-Imperial to reflect their
proximity and similarity in sylvatic arboviral activity.
Temporal trends in encephalitis rates from 1991 through
1999 were examined in conjunction with arboviral surveil-
lance data on sentinel chicken seroconversions to WEEV
and SLEV and on virus-positive mosquito pools. The coun-
ty-specific encephalitis rates for years with increased syl-
vatic arboviral activity were compared with the average
rate for the remaining years by using a two-sample test for
equality of proportions. The county of residence for
patients hospitalized in 1990 was not available, precluding
the inclusion of data from that year in the county-level
analyses. Analyses were conducted with EpiInfo 6 (version
6.04d; Centers for Disease Control and Prevention, Atlanta,
GA), SAS (version 8; SAS Institute, Cary, NC), and S-Plus
2000 (Professional Release 3; MathSoft, Inc., Seattle, WA).
Results
From 1990 through 1999, a total of 17,318 patients
were hospitalized with acute encephalitis; 3,511 (20.3%)
had a concurrent diagnosis of AIDS. The proportion of
encephalitis patients per year with AIDS decreased from
27% in 1990 to 9.5% in 1999 (chi-square test for trend =
475.9, p < 0.001). Annual rates for patients with and with-
out AIDS are shown in Figure 1. All subsequent analyses
were limited to the 13,807 patients without a concurrent
diagnosis of AIDS because of the distinct epidemiologic
characteristics of these two populations.
Unspecified encephalitis made up most of the
encephalitis diagnoses (55.7%), followed by specified
viral encephalitis (not arboviral) (17.6%) and “other” caus-
es of encephalitis (16.6%) (Table 1). Arthropodborne viral
disease constituted <1% of the encephalitis diagnoses,
with a total of 83 diagnoses among 82 patients. Some
patients had more than one ICD-9-CM code for encephali-
tis. Thus, the total number of diagnoses was greater than
the number of patients (Table 1).
The encephalitis rate was highest in infants (<1 year
old), followed by persons >65 years of age (Table 2). The
lowest rate was in persons 20–44 years of age. The chi-
square test for proportions indicated that the difference in
the rates between each age group was significant. Female
patients had a rate that was significantly higher than that of
male patients. 
A comparison of the annual number of patients hospi-
talized with encephalitis with the number of encephalitis
cases reported to CDHS is shown in Figure 2. On average,
the number of patients hospitalized with acute infectious or
unspecified encephalitis was 10-fold higher than the num-
ber of encephalitis cases reported to CDHS.
The epidemiology of encephalitis in specific counties
with sylvatic arboviral activity over the study period was
further examined to evaluate the potential role of undiag-
nosed arboviral encephalitis. Most patients hospitalized
with encephalitis in Sacramento-Yolo, Sutter-Yuba, and
Imperial-Riverside Counties were diagnosed with unspec-
ified encephalitis (Table 3). Only 10 patients were diag-
nosed with arthropodborne viral encephalitis, 2 from
Sacramento-Yolo, 1 from Sutter-Yuba, and 7 from
Riverside-Imperial. The number of admissions per quarter
was distributed fairly evenly for each bi-county area when
the data from 1991 through 1999 were combined (Table 3).
In no case did the proportion of hospitalizations for any
given quarter differ significantly from the null value of
25% (one-sample test for proportions: p > 0.05).
Annual encephalitis rates are shown for Sacramento-
Yolo (Figure 3), Sutter-Yuba (Figure 4), and Imperial-
Riverside (Figure 5) Counties from 1991 through 1999.
The encephalitis rates in these areas increased during some
years when increased arboviral activity was detected in
sentinel chickens flocks and mosquito pools (Table 4). For
instance, the encephalitis rate in Sutter-Yuba increased in
1997 (two-sample test for proportions: p = 0.041), when 41
sentinel chickens seroconverted to WEEV. A smaller
increase in the encephalitis rate was observed in
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Figure 1. Cumulative incidence of encephalitis hospitalizations in
California, 1990–1999 (n = 17,318).Sacramento-Yolo in 1996 and 1997 (two-sample test for
proportions: p = 0.028), when 20 and 18 sentinel chickens
seroconverted to WEEV, respectively. In contrast, the
encephalitis rates did not increase in Sacramento-Yolo and
Sutter-Yuba in 1993, when increased WEEV activity was
detected in sentinel chickens and mosquito pools. In
Riverside-Imperial, a small increase in the encephalitis
rate in 1991 (two-sample test for proportions, p = 0.004)
corresponded with an increase in detected WEEV and
SLEV activity in sentinel chickens and mosquito pools.
The proportion of encephalitis hospital admissions was
higher than expected (>25%) during the summer
(July–September) in Sutter-Yuba in 1997 (9/13 [69.2%])
and in Imperial-Riverside in 1991 (48/161 [29.8%]) (one-
sample test for proportions: p = 0.008 and p = 0.187,
respectively). No such increase occurred in Sacramento-
Yolo in 1996 and 1997 (34/135 [25.2%]). 
Discussion
The encephalitis rate showed an overall decrease during
the study period. The high proportion of patients with
unspecified encephalitis in this study (Table 1) is consis-
tent with findings from other studies and raises questions
about potential causes of these encephalitis cases (3,5).
Arboviral encephalitis was diagnosed in <1% of patients
hospitalized with acute encephalitis from 1990 through
1999. This finding indicates that this type of encephalitis is
either exceedingly rare in California or underdiagnosed. In
the absence of public health alerts during periods of epi-
zootic arboviral activity, clinicians may be disinclined to
pursue laboratory testing for arboviral agents because of a
low index of suspicion. Furthermore, outside of academic
interest, clinicians may not have much incentive to request
laboratory testing for specific agents for patients with viral
encephalitis if a specific diagnosis will not change the
course of treatment. 
ICD-9-CM codes used in the hospital discharge data-
base provide a standardized means of comparing data
between hospitals. Aprevious study used ICD-9-CM codes
in the National Hospital Discharge Survey to describe the
epidemiology of encephalitis (4). In both studies, the age-
specific encephalitis rates were highest among infants (<1
year) and the elderly (>65 years) (Table 2). This finding
may be due in part to infection with herpes simplex, which
is a common cause of nonepidemic, acute encephalitis that
occurs most frequently in children and the elderly (6).
Patients with AIDS, 92.5% of whom were men, were
excluded in the present study, which likely resulted in a
higher proportion of females compared to the national
study.
An advantage of using hospital discharge data to study
the epidemiology of encephalitis is that most patients with
encephalitis are likely to be hospitalized because of the
severity of the illness. Accordingly, these findings are more
readily generalized to the population of California, unlike
the passive surveillance data, which are limited by under-
reporting (21). In the present study, the annual number of
hospitalized encephalitis patients was approximately 10-
fold greater than the annual number of reported cases
(Figure 2). The actual degree of underreporting may be
less, as not all of the hospitalizations for encephalitis may
have been due to reportable causes. However, evidence
exists that arboviral encephalitis was underreported in
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Table 2. Characteristics of patients hospitalized with acute infectious or unspecified encephalitis, California, 1990–1999
a
 
  No. of patients
b  1995 population
c  Rate
 (95% CI)
d 
Sex       
Male  6,684  16,062,552  4.2 (4.1–4.3) 
Female  7,123  16,000,360  4.5 (4.3–4.6) 
Age group, y       
<1  868  552,649  15.7 (14.7–16.8) 
1–4  973  2,356,048  4.1 (3.9–4.4) 
5–19  2,350  6,801,354  3.5 (3.3–3.6) 
20–44  4,157  12,964,498  3.2 (3.1–3.3) 
45–64  2,707  5,958,743  4.5 (4.4–4.7 
65+  2,752  3,429,620  8.0 (7.7–8.3) 
Overall   13,807  32,062,912  4.3 (4.2–4.4) 
aPatients with a concurrent diagnosis of AIDS are excluded.  
bSource: Office of Statewide Health Planning and Development, Patient Discharge Data, Public Version A.   
cPopulation projections, State of California, Department of Finance.  
dCases per 10
5 person-years = (frequency/[1995 population x 10]) x 100,000; CI = confidence interval.  
Figure 2. Comparison of hospitalized versus reported encephalitis
in California, 1990–1999. Hospitalized patients with a concurrent
diagnosis of AIDS were excluded. California from 1990 through 1999, with 82 patients hospi-
talized with arthropodborne viral encephalitis but only 7
arboviral encephalitis cases reported. Encephalitis cases
with an unspecified cause may also be disproportionately
unreported, since encephalitis cases reported under the cur-
rent passive surveillance system request that the reporter
specify the cause as viral, bacterial, fungal, or parasitic. 
A disadvantage of relying on the public use hospital
discharge dataset to describe the epidemiology of
encephalitis is the lack of patient identifiers. This fact may
have resulted in multiple hospitalizations for individual
patients being included, as evidenced by the number of
hospitalizations for poliomyelitis and rabies (Table 1).
Another disadvantage is the lack of information on labora-
tory test results used to make diagnoses. While the high
proportion of unspecified encephalitis cases in the present
study possibly resulted from underuse of appropriate diag-
nostic tests, other studies do not support this hypothesis.
For instance, from 1956 through 1958, a total of 1,595
encephalitis patients were identified in Kern County
through active hospital-based surveillance and evaluated
by using a standard battery of tests (5). No cause was iden-
tified for 569 (36%) patients, and WEE and SLE account-
ed for <5% of cases per year. When advanced diagnostic
methods were used, the cause of encephalitis was identi-
fied for only 126 (38%) of 334 patients referred to the
California Encephalitis Program from June 1998 through
December 2000; no patients with arboviral encephalitis
were identified (3). These findings raise the possibility that
current diagnostic tests may simply be inadequate for iden-
tifying all possible causes of encephalitis. 
Given the limited number of encephalitis hospitaliza-
tions in any given county, all encephalitis diagnoses were
combined to provide a meaningful examination of county-
specific trends. Combining these diagnoses may have
obscured trends in specific disease agents, although most
of the patients in Sacramento-Yolo, Sutter-Yuba, and
Riverside-Imperial had a diagnosis of unspecified
encephalitis (Table 3). In Sacramento-Yolo and Sutter-
Yuba, concurrent increases in sylvatic WEEV transmis-
sion and in the rates of encephalitis hospitalizations in
1997 occurred (Table 4; Figures 3 and 4), increasing the
likelihood that a proportion of the unspecified encephali-
tis cases may have been due to arboviral encephalitis. A
similar pattern was observed in Imperial and Riverside
Counties in 1991, when levels of sylvatic WEEV and
SLEV transmission were particularly high (Table 4 and
Figure 5). The proportion of hospital admissions for
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Table 3. Diagnoses and month of admission for patients hospitalized with acute infectious or unspecified encephalitis in selected 
California counties, 1991–1999 
  Sacramento-Yolo  Sutter-Yuba  Imperial- Riverside 
1995 Population estimates   1,271,500  135,400  1,500,300 
Diagnosis (ICD-9-CM
a)  No. of encephalitis diagnoses (%)
b 
Encephalitis of unspecified cause    305 (60.2)  45 (70.3)  338 (58.2) 
Viral encephalitis with specified cause, not arboviral   74 (14.6)  11 (17.2)  112 (19.4) 
Other causes of encephalitis   76 (15.0)  5 (7.8)  64 (11.1) 
Postinfectious causes of encephalitis   38 (7.5)  1 (1.6)  45 (7.8) 
Bacterial/rickettsial causes of encephalitis   10 (2.0)  0 (0)  7 (1.2) 
Parasitic/protozoal causes of encephalitis   2 (0.4)  1 (1.6)  5 (0.09) 
Arthropodborne viral enceph alitis
c   2 (0.4)  1 (1.6)  7 (1.2) 
Total no. of encephalitis diagnoses
d  507  64  578 
Month of hospital admission   No. of admissions (%)  
January–March  112 (22.1)  17 (26.6)  160 (28.0) 
April–June  126 (24.9)  12 (18.8)  127 (22.2) 
July–September  139 (27.5)  15 (23.4)  140 (24.5) 
October–December  129 (25.5)  20 (31.3)  145 (25.3) 
Overall  506 (100)  64 (100)  572 (100) 
aInternational Classification of Diseases, 9th Revision, Clinical Modification.  
bSource: Office of Statewide Health Planning and Development, Patient Discharge Data, Public Version A.   
cArboviral encephalitis was diagnosed in Sacramento in 1992 (n = 1) and 1997 (n = 1), in Yuba in 1999 (n = 1), in Imperial in 1997 (n = 1), and in 
Riverside in 1991 (n = 3), 1994 (n = 2), and 1997 (n = 1).   
dTotal number o f encephalitis diagnoses in Sacramento -Yolo and Imperial -Riverside is greater than the number of encephalitis patients because some 
patients had two or more encephalitis diagnoses.  
 
Figure 3. Annual rate of encephalitis hospitalizations and annual
number of sentinel chicken seroconversions to Western equine
encephalomyelitis virus (WEEV) infection, Sacramento and Yolo
Counties, California, 1991–1999. Hospitalized patients with a con-
current diagnosis of AIDS were excluded. encephalitis in Sutter-Yuba in 1997 and Imperial-
Riverside in 1991 increased during the summer months,
when arboviral and enteroviral transmission most com-
monly occur (1). In contrast, statewide hospital admis-
sions for encephalitis were significantly higher during the
winter months, which indicates that arboviral encephalitis
is typically an unimportant contributor to encephalitis hos-
pitalizations. A study of encephalitis patients in California
from 1956 through 1958 also found an unexplained
increase in the proportion of cases with undetermined ori-
gin during the winter (5). One possible cause, lymphocyt-
ic choriomeningitis, occurs most commonly in the winter,
although it is thought to be rare (1).
The arboviral surveillance data used in the present
study lacked denominator data on mosquito pools and sen-
tinel chicken specimens tested for most years. In addition,
mosquito pool and sentinel chicken surveillance is not uni-
form across mosquito control districts. In spite of these
limitations, notable increases in arboviral activity in mos-
quito pools (Table 4) and sentinel chickens (Figures 3–5)
were observed in some years. Many potential reasons exist
for the lack of consistent correlation between sylvatic
arboviral activity and encephalitis rates. One possibility is
that mosquito population indices, sylvatic arboviral trans-
mission levels, or both, were not always sufficient to
increase the risk for human infection. For instance, Culex
tarsalis population indices are correlated with sentinel
chickens seroconversion rates for WEEV and SLEV (22).
A retrospective study of a 1989 SLE epizootic in the
Central Valley, with high Cx. tarsalis abundance, 70 virus-
positive mosquito pools, and seroconversion of 71% of
sentinel chickens, identified 28 (43%) of 65 aseptic menin-
gitis and encephalitis patients as SLE patients (9,23). In the
present study, the encephalitis rate in Imperial-Riverside
increased slightly in 1991, when WEEV and SLEV activi-
ty was detected in many mosquito pools and sentinel
chickens, but remained relatively unchanged in 1994 and
1995, when many sentinel chickens seroconverted but few
mosquito pools were virus-positive. Another possible con-
tributor to the study findings is variation in the virulence of
circulating arboviruses over the study period. Three phe-
notypes of WEEV, which differed in their virulence prop-
erties in adult mice, were isolated from mosquito pools
collected in California from 1991 through 1995 (24).
Lastly, sylvatic arboviral activity and encephalitis rates
may not be correlated. For instance, no encephalitis cases
were detected during an intense WNV epizootic in
Connecticut (25). In fact, an aseptic meningitis epidemic
attributable to enteroviruses was detected during an avian
epizootic of WNV, while no WNV meningitis cases were
detected (26). 
Many factors could explain the observed decrease in
the incidence of clinical WEE and SLE cases since the
1960s. Mosquito control and water management programs
have been effective at reducing mosquito vector popula-
tions (27). Changes in human behavior may also have
coincided with the decrease in the incidence of arboviral
illness (28). With the advent of television and air-condi-
tioning, people are more likely to remain indoors during
twilight hours, when peak feeding by vector species takes
place. Earlier research showed rural residents to be at high-
er risk for arboviral illness than urban residents (29). With
changes in land use over the past century, a greater propor-
tion of the human population now resides in urban and
suburban settings. A 1995 California study of outpatients
attending county health department clinics found a signif-
icantly higher seroprevalence of WEEV among residents
of rural Imperial and Sutter Counties than Sacramento
County residents; the seroprevalence for SLEV was signif-
icantly higher in Imperial than in both Sacramento and
Sutter Counties (30). However, although this study was
conducted in areas with both sporadic and enzootic WEEV
and SLEV transmission, the overall seroprevalence levels
for both viruses were low.
The methods used in the present study are useful for
evaluating trends in the incidence of emerging or potential-
ly emerging diseases. The epidemiology of arboviral
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Figure 4. Annual rate of encephalitis hospitalizations and annual
number of sentinel chicken seroconversions to Western equine
encephalomyelitis virus (WEEV) infection, Sutter and Yuba
Counties, California, 1991–1999. Hospitalized patients with a con-
current diagnosis of AIDS were excluded.
Figure 5. Annual rate of encephalitis hospitalizations and annual
number of sentinel chicken seroconversions, Imperial and
Riverside Counties, California, 1991–1999. Hospitalized patients
with a concurrent diagnosis of AIDS were excluded. SLEV, St.
Louis encephalitis virus; WEEV, Western equine encephalitis virus.encephalitis will likely change with the establishment of
WNV in California, making active hospital-based surveil-
lance for arboviral disease an important supplement to tra-
ditional passive reporting. These findings suggest that
unrecognized arboviral encephalitis has not constituted a
large proportion of the unspecified encephalitis patients
who were hospitalized from 1991 through 1999. However,
the study results do indicate the potential utility of intensi-
fied surveillance efforts during periods of increased sylvat-
ic arboviral activity. During such periods, implementing
active hospital-based surveillance for encephalitis, acute
flaccid paralysis, and aseptic meningitis, with collection
and testing of diagnostic specimens, may result in detecting
cases of arboviral disease that would otherwise go undiag-
nosed and unreported.
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